InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,718.21
(
1.78%
)
US TECH 100
19,357.20
(
2.65%
)
Dow Jones
42,031.27
(
1.27%
)
Brent Oil
74.19
(
2.49%
)
Bitcoin
63,454.83
(
2.89%
)
Post# of 8164
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Golden Cross

Send PM Follow Ignore
Followers 3349
Posts 85922
Boards Moderated 5
Alias Born 10/05/2005

Golden Cross

Re: None

Wednesday, 04/14/2021 2:40:58 AM

Wednesday, April 14, 2021 2:40:58 AM

Post# of 8164
RGBP Regen BioPharma signed a license agreement with Oncology Pharma for intellectual property pertaining to mRNA (messenger RNA) to be used in developing a therapy for treating pancreatic cancer.
https://insiderfinancial.com/regen-biopharma-about-to-become-a-major-pharma-player/181241/

Give Me A Follow If You Want To Consistently Find Winners!
Click Here:
https://investorshub.advfn.com/boards/profilea.aspx?user=61470

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up